Bini, C., Marcellusi, A., Mennini, F. S., Ripoli, S., Fioravanti, L., Paly, V. F., Molinari, A., Morelli, P., Krotneva, S., & Li, S. (2024). Cost-effectiveness of brentuximab vedotin plus chemotherapy as frontline treatment of stage IV Hodgkin lymphoma in Italy. Global and Regional Health Technology Assessment, 11(1), 248–257. https://doi.org/10.33393/grhta.2024.3167